A Pilot Study of Multiplex Ligation-Dependent Probe Amplification Evaluation of Copy Number Variations in Romanian Children with Congenital Heart Defects

Alexandru Cristian Bolunduț,Florina Nazarie,Cecilia Lazea,Crina Șufană,Diana Miclea,Călin Lazăr,Carmen Mihaela Mihu
DOI: https://doi.org/10.3390/genes15020207
IF: 4.141
2024-02-06
Genes
Abstract:Congenital heart defects (CHDs) have had an increasing prevalence over the last decades, being one of the most common congenital defects. Their etiopathogenesis is multifactorial in origin. About 10–15% of all CHD can be attributed to copy number variations (CNVs), a type of submicroscopic structural genetic alterations. The aim of this study was to evaluate the involvement of CNVs in the development of congenital heart defects. We performed a cohort study investigating the presence of CNVs in the 22q11.2 region and GATA4, TBX5, NKX2-5, BMP4, and CRELD1 genes in patients with syndromic and isolated CHDs. A total of 56 patients were included in the study, half of them (28 subjects) being classified as syndromic. The most common heart defect in our study population was ventricular septal defect (VSD) at 39.28%. There were no statistically significant differences between the two groups in terms of CHD-type distribution, demographical, and clinical features, with the exceptions of birth length, weight, and length at the time of blood sampling, that were significantly lower in the syndromic group. Through multiplex ligation-dependent probe amplification (MLPA) analysis, we found two heterozygous deletions in the 22q11.2 region, both in patients from the syndromic group. No CNVs involving GATA4, NKX2-5, TBX5, BMP4, and CRELD1 genes were identified in our study. We conclude that the MLPA assay may be used as a first genetic test in patients with syndromic CHD and that the 22q11.2 region may be included in the panels used for screening these patients.
genetics & heredity
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to evaluate the role of copy number variations (CNVs) in Romanian children with congenital heart defects (CHDs). Specifically, the researchers hope to detect whether there are CNVs in the 22q11.2 region and in the GATA4, TBX5, NKX2 - 5, BMP4 and CRELD1 genes through the Multiplex Ligation - Dependent Probe Amplification (MLPA) technique, and explore the association between these genetic variations and congenital heart diseases. ### Research Background Congenital heart disease is one of the most common congenital defects, and its incidence has increased in the past few decades. The etiology of congenital heart disease is usually multifactorial, and about 10 - 15% of cases can be attributed to copy number variations. Deletion in the 22q11.2 region is one of the most common CNVs and is associated with multiple congenital heart diseases. ### Research Objectives The main objectives of this study are: 1. **Evaluate the role of CNVs in the development of congenital heart disease**: Detect CNVs in the 22q11.2 region and specific genes (GATA4, TBX5, NKX2 - 5, BMP4 and CRELD1) through the MLPA technique. 2. **Explore the relationship between CNVs and the phenotype of congenital heart disease**: Analyze the distribution of CNVs in patients with syndromic and isolated congenital heart diseases and their clinical characteristics. ### Research Methods - **Research Subjects**: 56 children with congenital heart disease, half of them (28) were classified as syndromic. - **Detection Method**: Use the MLPA technique to detect CNVs in the 22q11.2 region and the above - mentioned genes. - **Data Analysis**: Statistically analyze the clinical characteristics of patients and the detection results of CNVs. ### Main Findings - **CNVs Detection Results**: Two heterozygous deletions were found in 28 syndromic patients, all located in the 22q11.2 region, while no CNVs were found in isolated patients. - **Clinical Characteristics**: The birth length, height and weight at blood collection of syndromic patients were significantly lower than those of isolated patients. - **Gene Function**: Deletion in the 22q11.2 region may affect the functions of multiple genes, especially the TBX1 and DGCR8 genes, which play a key role in heart development. ### Conclusions - **Application of MLPA Technique**: The MLPA technique can be used as the first - choice genetic test for screening patients with syndromic congenital heart disease. - **Importance of 22q11.2 Region**: Deletion in the 22q11.2 region is relatively common in patients with syndromic congenital heart disease, and it is recommended to include it in the screening panel. ### Significance Understanding the genetic background of congenital heart disease is of great significance for clinical diagnosis and treatment, which is helpful for early diagnosis, evaluating the recurrence risk, predicting the prognosis and optimizing the treatment plan. Especially for patients with 22q11.2 deletion, the survival rate and complication rate after surgical repair are low, and they need a longer time of cardiopulmonary bypass and postoperative intensive care.